Affinity Asset Advisors, LLC has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $579 Million distributed in 86 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Xenon Pharmaceuticals Inc. with a value of $45M, Nuvalent, Inc. with a value of $34.5M, Arcellx, Inc. with a value of $33.4M, Alkermes Plc. with a value of $28M, and Teva Pharmaceutical Industries LTD with a value of $25.2M.
Examining the 13F form we can see an decrease of $156M in the current position value, from $735M to 579M.
Affinity Asset Advisors, LLC is based out at New York, NY
Below you can find more details about Affinity Asset Advisors, LLC portfolio as well as his latest detailed transactions.
